Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 27, 2015 - Issue 10
524
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

Acceptability of drug detection monitoring among participants in an open-label pre-exposure prophylaxis study

, , , , , , , & show all
Pages 1199-1204 | Received 26 Aug 2014, Accepted 06 Apr 2015, Published online: 22 May 2015

References

  • Anderson, P. L., Glidden, D. V., Liu, A., Buchbinder, S., Lama, J. R., Guanira, J. V., … Grant, R. M. (2012). Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Science Translational Medicine, 4, 151ra125. doi:10.1126/scitranslmed.3004006
  • Burack, J. (2013). CRUSH – Connecting resources for urban sexual health. Retrieved January 7, 2014, from http://www.californiaaidsresearch.org/funded_research/abstracts/2012_burack.html
  • Castillo-Mancilla, J. R., Zheng, J. H., Rower, J. E., Meditz, A., Gardner, E. M., Predhomme, J., … Anderson, P. L. (2013). Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. AIDS Res Hum Retroviruses, 29, 384–390. doi:10.1089/AID.2012.0089
  • Eakle, R., Venter, W. D. F., & Rees, H. (2013). Pre-exposure prophylaxis for HIV prevention: Ready for prime time in South Africa? South African Medical Journal, 103, 515–516. doi:10.7196/samj.6937
  • Gill, C. J., Sabin, L. L., Hamer, D. H., Keyi, X., Jianbo, Z., Li, T., … DeSilva, M. B. (2010). Importance of dose timing to achieving undetectable viral loads. AIDS and Behavior, 14, 785–793. doi:10.1007/s10461-009-9555-9
  • Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K.R., Mehrotra, M., … Glidden, D. V. (2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. The Lancet, 14, 820–829. doi:10.1016/S1473-3099(14)70847-3
  • Guest, G. (2006). How many interviews are enough? An experiment with data saturation and variability. Field Methods, 18(1), 59–82. doi:10.1177/1525822X05279903
  • Hsieh, H.-F., & Shannon, S. E. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15, 1277–1288. doi:10.1177/1049732305276687
  • Liu, A. Y., Yang, Q., Huang, Y., Bacchetti, P., Anderson, P. L., Jin, C., … Gandhi, M. (2014). Strong relationship between oral dose and tenofovir hair levels in a randomized trial: Hair as a potential adherence measure for pre-exposure prophylaxis (PrEP). PLoS one, 9(1), e83736. doi:10.1371/journal.pone.0083736
  • Sabin, L. L., DeSilva, M. B., Hamer, D. H., Xu, K., Zhang, J., Li, T., … Gill C. J. (2010). Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in China. AIDS and Behavior, 14, 580–589. doi:10.1007/s10461-009-9615-1
  • Stirratt, M. J., & Gordon, C. M. (2008). Adherence to biomedical HIV prevention methods: Considerations drawn from HIV treatment adherence research. Current HIV/AIDS Reports, 5, 186–192. doi:10.1007/s11904-008-0027-z
  • Vargas, L., Amico, K. R. A., Goicochea, P., Liu, A., McMahan, V., Montoya, O., … Grant, R. M. (2010). Pill – taking support and assessment: Self reported perceptions of participants in a PrEP trial. Paper presented at the 5th International Conference on HIV Treatment Adherence, Miami, FL.
  • Ware, N. C., Wyatt, M. A., Haberer, J. E., Baeten, J. M., Kintu, A., Psaros, C., … Bangsberg, D. R. (2012). What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples. JAIDS Journal of Acquired Immune Deficiency Syndromes, 59, 463–468. doi:10.1097/QAI.0b013e31824a060b
  • Wohl, A., & Landovitz, R. (2013). LA County PATH: PrEP and TLC+ for HIV Prevention. Retrieved January 7, 2014, from http://www.californiaaidsresearch.org/funded_research/abstracts/2012_wohl.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.